CASP9) and caspase-10 (CASP10%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP10) are two key controllers of apoptosis and play impor'/> Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population
首页> 外文期刊>Journal of Zhejiang University. Science, B >Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population
【24h】

Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population

机译:Casp9,Casp10基因多态性和茶叶饮用与汉族人群结直肠癌风险的关联

获取原文
           

摘要

The initiators caspase-9 (CASP9%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP9) and caspase-10 (CASP10%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP10) are two key controllers of apoptosis and play important roles in carcinogenesis. This study aims to explore the association between CASPs gene polymorphisms and colorectal cancer (CRC) susceptibility in a population-based study. A two-stage designed population-based case-control study was carried out, including a testing set with 300 cases and 296 controls and a validation set with 206 cases and 845 controls. A total of eight tag selected single nucleotide polymorphisms (SNPs) in CASP9%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP9 and CASP10%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP10 were chosen based on HapMap and the National Center of Biotechnology Information (NCBI) datasets and genotyped by restriction fragment length polymorphism (RFLP) assay. Multivariate logistic regression models were applied to evaluate the association of SNPs with CRC risk. In the first stage, from eight tag SNPs, three polymorphisms rs4646077 (odds ratio (OR)AA+AG: 0.654, 95% confidence interval (CI): 0.406–1.055; P=0.082), rs4233532 (ORCC: 1.667, 95% CI: 0.967–2.876; ORCT: 1.435, 95% CI: 0.998–2.063; P=0.077), and rs2881930 (ORCC: 0.263, 95% CI: 0.095–0.728, P=0.036) showed possible association with CRC risk. However, none of the three SNPs, rs4646077 (ORAA+AG: 1.233, 95% CI: 0.903–1.683), rs4233532 (ORCC: 0.892, 95% CI: 0.640–1.243; ORCT: 1.134, 95% CI: 0.897–1.433), and rs2881930 (ORCC: 1.096, 95% CI: 0.620–1.938; ORCT: 1.009, 95% CI: 0.801–1.271), remained significant with CRC risk in the validation set, even after stratification for different tumor locations (colon or rectum). In addition, never tea drinking was associated with a significantly increased risk of CRC in testing set together with validation set (OR: 1.755, 95% CI: 1.319–2.334). Our results found that polymorphisms of CASP9%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP9 and CASP10%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>CASP10 genes may not contribute to CRC risk in Chinese population and thereby the large-scale case-control studies might be in consideration. In addition, tea drinking was a protective factor for CRC.
机译:引发剂CASPase-9(CASP9%29和CK%5B%5D =摘要&CK%5B%5D =关键字'> CASP9)和CASPase-10(CASP10%29&CK%5B%5d = Abstract&CK%5b%5d =关键字'> casp10)是凋亡的两个关键控制器,并在致癌中发挥重要作用。本研究旨在探讨患者基因多态性与结肠直肠癌(CRC)易感性在基于人群的研究中的关联。进行了两阶段设计的基于人口的案例控制研究,包​​括使用300个案例和296个控制的测试和296个案例和845个控制。 CASP9%29%29%的单核苷酸多态性(SNP)总共八个标签(SNP),CK%5b%5d =&ck%5b%5d =关键词'casp9和casp10%29&ck%5b%5d = abstract&ck%5b%5d =关键词'casp10基于HAPMAP和国家生物技术信息(NCBI)数据集和基因分型基于HAPMAP和国家的基因分型基于限制性片段长度多态性(RFLP)测定。应用多变量逻辑回归模型来评估SNP与CRC风险的关联。在第一阶段,来自八个标签SNP,三种多态性RS4646077(OTS比率(或)AA + AG:0.654,95%置信区间(CI):0.046-1.055; P = 0.082),RS4233532(ORCC:1.667,95%) CI:0.967-2.876; ORCT:1.435,95%CI:0.998-2.063; P = 0.077)和RS2881930(ORCC:0.263,95%CI:0.095-0.728,P = 0.036)显示出与CRC风险的可能性。然而,三个SNP中没有一个RS4646077(ORAA + AG:1.233,95%CI:0.903-1.683),RS4233532(ORCC:0.892,95%CI:0.640-1.243; ORCT:1.134,95%CI:0.897-1.433 )和RS2881930(ORCC:1.096,95%CI:0.620-1.938; ORCT:1.009,95%CI:0.801-1.271)在验证装置中,即使在不同肿瘤位置(结肠或结肠)的分层之后,CRC风险仍然显着。直肠)。此外,茶饮料与验证集合(或:1.755,95%CI:1.319-2.334)的测试组合在一起,CRC的风险显着增加。我们的结果发现,CASP9%29的多态性29&CK%5B%5D =摘要和CK%5B%5D =关键字'CASP9和CASP10%29&CK%5B%5D =摘要&CK%5B%5d =关键词'CASP10基因可能对CRC风险没有贡献在中国人口中,从而可能考虑大规模的案例控制研究。此外,茶饮料是CRC的保护因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号